Daily News Watch

News Home Page

Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.

X-Static Bacteria-Resistant Curtains Protect the Fabrics Surrounding Patients

X-STATIC Antimicrobial Technology has been chosen by Nebraska Methodist Hospital to elevate its standard of care for fabrics in the healthcare environment. The facility will install bacteria-resistant Arc-Com privacy curtains powered by X-STATIC in the Post Anesthesia Care Unit (PACU) of its new surgery center.Terry Micheels, MSN, RN, CIC, and the service Leader of the epidemiology department at Nebraska Methodist Hospital explained, "We have things we do to address soft surface fabric risk in the ...

Posted on: November 27, 2014
Association for Molecular Pathology Announces 2014 Award Recipients

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, announced its 2014 award winners. Recipients of the Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award, and AMP Meritorious Service Award were presented at the recent AMP Annual Meeting in National ...

Posted on: November 26, 2014
Enterome Enters into a Microbiome-Based Development Collaboration with AbbVie in Crohn's Disease

Enterome Bioscience, a pioneer in the development of therapeutic solutions (drugs and diagnostics) based on a thorough understanding of the gut microbiome, announces that it has entered into a collaborative development agreement with AbbVie. The alliance is anchored around Enterome's  proprietary metagenomic biomarker portfolio and technologies that may enable the development of novel diagnostic products to support personalized therapies and the development of new drugs in microbiome-related ...

Posted on: November 26, 2014
Biocept Launches Lung Blood-Based Liquid Biopsy Testing for NSCLC Indications

Biocept Launches Lung Blood-Based Liquid Biopsy Testing for NSCLC IndicationsBiocept Inc., a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor Cells (CTCs), has announced the launch of its lung cancer liquid biopsy testing that will be performed at the company's CLIA-certified and CAP-accredited laboratory. By launching blood-based biomarker testing for non-small cell lung cancer (NSCLC), along with the previously commercialized ...

Posted on: November 25, 2014
QIAGEN Signs Ninth Master Collaboration Agreement for CDx

QIAGEN N.V. has announced it has entered into a master collaboration agreement with the Swiss pharmaceutical company Novartis AG to enable the development and commercialization of companion diagnostics to be paired with existing Novartis pharmaceutical products as well as compounds in its development pipeline.The non-exclusive agreement with Novartis creates a framework for collaborations that would include developing QIAGEN companion diagnostics to guide treatment decisions for Novartis pharmaceutical ...

Posted on: November 24, 2014
Doctors Charging Medicare Millions to Test Seniors for PCP, Says Consumer Watchdog

Doctors are charging Medicare millions for apparently unnecessary tests of seniors for illegal drugs like cocaine and PCP according to a Wall Street Journal analysis of Medicare payment data. A San Diego company, Millennium Laboratories, was paid $190 million from Medicare in 2012 including $4.5 million for PCP tests, more than any other California company."Testing seniors for PCP and ecstasy is a comic but all too common example of skyrocketing costs generated by doctors who order unnecessary but ...

Posted on: November 23, 2014
AACC Joins AMA, Others Urging FDA to Withdraw Proposed Framework for Laboratory Developed Tests

The FDA issued its long-awaited proposal on Oct. 3 for overseeing laboratory developed tests -- medical tests that are created and used within a single lab, and often developed to fulfill unmet clinical needs. AACC is concerned that this guidance could hinder the ability of labs to provide physicians with the vital information they need to treat patients, and has joined the American Medical Association (AMA), American Hospital Association (AHA), and 48 other major healthcare organizations in ...

Posted on: November 20, 2014
BloodCenter of Wisconsin Launches Next Generation Sequencing HemeOnc Panel

BloodCenter of Wisconsin's Diagnostic Laboratories have announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.Genetic profiling of hematologic malignancies through NGS is transformative technology for cancer diagnostics and patient care.BloodCenter's ...

Posted on: November 20, 2014
New Test Will Combat Major Cause of Preventable Blindness In Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, has announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics. Designed for use in disease surveillance, the antibody-based test is faster, easier-to-use, and more acceptable to impacted communities than the current option. It is the first in a suite of ...

Posted on: November 19, 2014
PDI Prevantics Device Swab Is Only 3.15% Chlorhexidine Gluconate/70% Alcohol Solution with FDA Market Authorization

Clinical investigators recently released results from the first and only randomized, cross-over, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate (CHG) and 70% Isopropyl Alcohol over 70% Isopropyl Alcohol alone in disinfecting needleless connectors. The study was funded by the CDC Epicenters Program and executed by Rush University in Chicago, Ill. The results were presented at the 2014 IDWeek Conference in Philadelphia on Oct.11.The ...

Posted on: November 18, 2014
Quest Diagnostics Introduces BRCAvantage Plus, Providing New Choices in Genetic Breast Cancer Risk Testing

Quest Diagnostics, the world's leading provider of diagnostic information services, has announced BRCAvantage Plus, the company's first suite of lab-developed test services for assessing genetic breast cancer risk based on clinically validated non-BRCA as well as BRCA genes. The new service is now available in all 50 states.BRCAvantage Plus is the first major line extension to BRCAvantage, a suite of lab-developed tests for assessing BRCA1 and BRCA2 gene mutations launched ...

Posted on: November 17, 2014
University Hospitals Case Medical Center Expands Use of Data Analytics to Include Microbiology and Billing/Accounts Receivables

Viewics Inc. today has announced that University Hospitals Case Medical Center in Cleveland, Ohio, is expanding its use of Viewics Health Insighter (VHI) by adding the solution on its microbiology department's SCC Soft Computer Microbiology information system, SoftMic, as well as their billing and accounts receivable system SoftA/R. UH Case Medical Center went live with VHI in November 2013 within their clinical and anatomic pathology laboratories. Due to the return on investment they have received within ...

Posted on: November 17, 2014
Scientists Generate First Human Stomach Tissue in Lab with Stem Cells

Scientists used pluripotent stem cells to generate functional, three-dimensional human stomach tissue in a laboratory - creating an unprecedented tool for researching the development and diseases of an organ central to several public health crises, ranging from cancer to diabetes.Scientists at Cincinnati Children's Hospital Medical Center reported in Nature they used human pluripotent stem cells - which can become any cell type in the body - to grow a miniature version of the stomach. In collaboration ...

Posted on: November 16, 2014
Medicare to Cover Combinatorial Genetic Testing to Guide Individualized Selection Of Depression Meds

The promise of genetic testing to guide more effective treatment for millions of older and disabled Americans suffering from depression has shifted from a futuristic vision to a practical reality.Medicare has issued a Local Coverage Determination (LCD) that will provide coverage for GeneSight Psychotropic, the first combinatorial pharmacogenomic test to help guide medication decisions for depression.  Prior to GeneSight, no psychiatric pharmacogenomic test has achieved a favorable coverage decision ...

Posted on: November 14, 2014
Beckman Coulter's Hemoglobin A1c Test Available on All Clinical UniCel DxC and AU Chemistry Systems

Beckman Coulter Diagnostics has launched its next generation Hemoglobin A1c (HbA1c) assay with improved performance across all of its chemistry systems. The assay has been standardized for use on all platforms of the company's AU clinical chemistry systems for offline sample preparation use, in addition to online sample preparation use on the company's UniCel DxC systems. FDA 510(k) clearance has been received for this assay on both the AU and DxC series of chemistry analyzers. The next generation ...

Posted on: November 13, 2014
View Archives